Monthly roundup · Biotech · June 2026
Biotech startup funding, June 2026: Flourish's $500M Growth leads 23 rounds
We read 23 equity rounds in Biotech announced in June 2026, raising $2.4B between them: 9% of all the rounds we read that month and 7% of the money. The largest was Flourish's $500M Growth, led by Google Ventures and Lux Capital. The median seed round was $7.6M, against $6.7M over the last twelve months in Biotech; at Series A it was $95M. Frazier Life Sciences led the most rounds, with 2.
The biggest rounds
- 1FFlourishGrowth · United States · led by Google Ventures, Lux Capital$500M
- 2
NewLimitSeries C · United States · led by Founders Fund$435M - 3ccAMPfield Therapeutics, Inc.Series A · United States · led by Frazier Life Sciences$180M
- 4
Element BiosciencesGrowth · United States · led by Samsung Electronics$175M - 5BBionyra PharmaSeries A · France · led by Sofinnova Partners, Jeito Capital$165M
- 6
SonoTheraSeries B · United States · led by ARCH Venture Partners, Perceptive Advisors$125M - 7RRQ BioSeries A · United Kingdom · led by Frazier Life Sciences$115M
- 8
Ethyreal BioSeries A · United States · led by Atlas Venture, Medicxi Ventures$101M - 9CCity TherapeuticsSeries B · United States · led by Sofinnova Investments, Viking Global$100M
- 10CCollateSeries A · United States · led by Redpoint$95M
Day by day
Equity rounds in Biotech announced each day of June. The busiest day was 2 June, with 4.
By stage, against the year
Each stage's median this month beside its twelve-month median: the sector's own where we hold enough rounds for a benchmark, otherwise the one across all sectors.
The most active leads
Firms that led two or more of the month's rounds in Biotech.
Where
- United States12
- United Kingdom2
- France1
- Austria1
- Italy1
- Netherlands1
- Singapore1
- Hong Kong SAR China1
United States had the most Biotech rounds this month.
Against the month
- Rounds, Biotech23
- Rounds, all sectors245
- Raised, Biotech$2.4B
- Raised, all sectors$35B